Author:
Qian Haili,Gao Feng,Wang Haijuan,Ma Fei
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference26 articles.
1. Weinmann M, Jeremic B, Toomes H, Friedel G, Bamberg M: Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer. Lung Cancer. 2003, 39 (3): 233-253. 10.1016/S0169-5002(02)00454-3.
2. Roberts PJ: Clinical use of crizotinib for the treatment of non-small cell lung cancer. Biologics. 2013, 7: 91-101.
3. Fukuoka M, Wu YL, Thongprasert S, Sunpaweravong P, Leong SS, Sriuranpong V, Chao TY, Nakagawa K, Chu DT, Saijo N, Duffield EL, Rukazenkov Y, Speake G, Jiang H, Armour AA, To KF, Yang JC, Mok TS: Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol. 2011, 29 (21): 2866-2874. 10.1200/JCO.2010.33.4235.
4. Klastersky J, Paesmans M: Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results. Lung Cancer. 2001, 34 (Suppl 4): S95-S101.
5. American Cancer Society: Cancer Facts & Figures 2013. 2013, http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/,
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献